Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Size and Structure of Viral Genomes01:26

Size and Structure of Viral Genomes

Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Viral Replication: Lytic Cycle01:20

Viral Replication: Lytic Cycle

Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
Viral Replication: Lysogenic Cycle01:16

Viral Replication: Lysogenic Cycle

The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects its...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pre- and postoperative membranous urethral length on multiparametric magnetic resonance imaging predict stage-specific 0-pad continence recovery after robot-assisted radical prostatectomy.

Translational andrology and urology·2026
Same authorSame journal

A Delay Differential Model for Antiviral Treatment and Rebound Dynamics.

Mathematical biosciences·2026
Same author

Exploring memory effects: Sparse identification in vector-borne diseases.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Dynamics of infectious disease spread between transportation hubs and surrounding communities.

Infectious Disease Modelling·2026
Same author

An agent-based platform for simulating the impact of chlamydia vaccine in the US population.

Nature communications·2026
Same author

Lipid metabolism dysregulation in rheumatoid arthritis: from multi-omics discovery to adjunctive therapy with conjugated linoleic acid.

Arthritis research & therapy·2026

Related Experiment Video

Updated: Jun 24, 2026

A Rat Model of EcoHIV Brain Infection
08:48

A Rat Model of EcoHIV Brain Infection

Published on: January 21, 2021

Oscillatory viral dynamics in a delayed HIV pathogenesis model.

Yan Wang1, Yicang Zhou, Jianhong Wu

  • 1Department of Applied Mathematics, Xi'an Jiaotong University, Xi'an, Shaanxi 710049, PR China.

Mathematical Biosciences
|March 31, 2009
PubMed
Summary

This study models HIV infection dynamics with antiretroviral therapy. Time delays in HIV replication can cause oscillations, leading to sustained viral presence even with treatment.

More Related Videos

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
09:54

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Published on: December 3, 2019

Related Experiment Videos

Last Updated: Jun 24, 2026

A Rat Model of EcoHIV Brain Infection
08:48

A Rat Model of EcoHIV Brain Infection

Published on: January 21, 2021

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
09:54

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Published on: December 3, 2019

Area of Science:

  • Mathematical modeling
  • Virology
  • Epidemiology

Background:

  • Antiretroviral therapy (ART) is crucial for managing HIV infection.
  • HIV replication dynamics and their interaction with treatment are complex.
  • Understanding disease progression and treatment efficacy requires robust mathematical models.

Purpose of the Study:

  • To analyze an HIV pathogenesis model that includes antiretroviral therapy and HIV replication time.
  • To investigate the stability of disease equilibria and the occurrence of Hopf bifurcations.
  • To determine the impact of time delays on disease dynamics and treatment outcomes.

Main Methods:

  • Mathematical analysis of differential equations.
  • Investigation of equilibrium points and their stability.
  • Bifurcation analysis to identify transitions to oscillatory behavior.

Main Results:

  • Sufficient conditions for the global stability of the uninfected steady state were derived.
  • Time delays do not affect the stability of the uninfected state.
  • Time delays can destabilize the infected steady state, causing Hopf bifurcations to periodic solutions.

Conclusions:

  • Time delays in HIV replication play a critical role in disease dynamics.
  • Hopf bifurcations can lead to sustained oscillations, indicating persistent infection despite ART.
  • Model findings highlight the importance of considering replication time and delays in HIV treatment strategies.